Dublin-based Cardinal Health reported record revenue and operating earnings Tuesday in its recently completed 2016 fiscal year.
And although the drug distributor and medical-products company predicted a decline in adjusted earnings per share in this quarter, shares rose $2.51 per share, or 3.1 percent, on Tuesday to close at $84.92.
Comments are closed.